This blog discusses the first-ever human hookworm vaccine, HOOKVAC, currently being tested in Gabon. The HOOKVAC vaccine aims to reduce hookworm infection, which affects more than half a billion people worldwide and is one of the most ubiquitous infections of the poor. The authors assert that it could also be the first vaccine to indirectly reduce iron-deficiency anemia (IDA), which is caused by several factors including hookworm.
Health Affairs Blog, February 2015